On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators by May 2020 and achieve a four-fold increase by the third quarter of 2020. This plan builds on Philipsﾒ initial production increase in the first three months of the year, which already enabled the supply of additional ventilators ﾖ that are critical for the treatment of COVID-19 patients ﾖ to hospitals in the most affected regions in China, southern Europe and the US. To further address the huge global demand, Philips introduced its new Philips Respironics E30 ventilator, a versatile and easy-to-use non-invasive and invasive ventilator, which has been designed for large scale production.